Microevolution of a standard strain of Cryptococcus neoformans resulting in differences in virulence and other phenotypes

Infection and Immunity

Volumn 66, Issue 1, 1998, Pages 89-97

  Franzot, Sarah P ^a,b   Mukherjee, Jean ^a,c   Cherniak, Robert ^d   Chen, Lin Chi ^a   Hamdan, Junia S ^b   Casadevall, Arturo ^a,e  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^d GEORGIA STATE UNIVERSITY   (United States)

^e Department of Medicine ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; FLUOROURACIL; FUNGAL DNA; FUNGAL PROTEIN; MELANIN; PROTEINASE;

ADAPTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHROMOSOME POLYMORPHISM; CHROMOSOME SIZE; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; DRUG SENSITIVITY; EVOLUTION; FUNGUS CULTURE; FUNGUS GROWTH; MELANOGENESIS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; VIRULENCE;

EID: 0031984903     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.1.89-97.1998     Document Type: Article

References (50)

1. Block, E. R., A. E. Jennings, and J, E. Bennett. 1973. 5-Fluorocytosine resistance in Cryptococcus neoformans. Antimicrob. Agents and Chemother. 3:649-656.
2. Brandt, M. E., M. A. Pfaller, R. A. Hajjeh, E. A. Graviss, J. Ress, E. D. Spitzer, R. W. Pinner, L. W. Mayer, and the Cryptococcal Disease Active Surveillance Group. 1996. Molecular subtypes and antifungal susceptibilities of serial Cryptococcus neoformans isolates in human immunodeficiency virus-associated cryptococcosis. J. Infect. Dis. 174:812-820.
3. Branham, S. E. 1940. The meningococcus (Neisseria intracellularis). Bacteriol. Rev. 17:175-188.
4. Casadevall, A., L. F. Freundlich, L. Marsh, and M. Seharff. 1992. Extensive allelic variation in Cryptococcus neoformam. J. Clin. Microbiol. 30:1080-1084.
5. Chen, L.-C., E. S. Blank, and A. Casadevall. 1996. Extracellular proteinase activity of Cryptococcus neoformans. Clin. Diugn. Lab. Immunol. 3:570-574.
6. Chen, L.-C., L. Pirofiski, and A. Casadevall. 1997. Extracellular proteins of Cryptococcus neoformans and host antibody response. Infect. Immun. 65:2599-2605.
7. Cherniak, R., L. C. Morris, T. Belay, E. D. Spitzer, and A. Casadevall. 1995. Variation in the structure of glucuronoxylomannan in isolates from patients with recurrent cryptococcal meningitis. Infect. Immun. 63:1899-1905.
8. 1H-NMR spectra of glucuronoxylomannans using a computer based neural network, abstr. F39. In Abstracts of the 97th General Meeting of the American Society for Microbiology 1997. American Society for Microbiology, Washington. D.C.
9. Currie, B., H. Sanati, A. S. Ibrahim, J. E. Edwards, Jr., A. Casadevall, and M. Ghannoum. 1995. Sterol compositions and susceptibilities to amphotericin B of environmental Cryptococcus neoformans isolates are changed by murine passage. Antimicrob. Agents Chemother. 39:1934-1937.
10. Currie, B. P., L. F. Freundlich, and A. Casadevall. 1994. Restriction fragment length polymorphism analysis of Cryptococcus neoformans isolates from environmental (pigeon excreta) and clinical sources in New York City. J. Clin. Microbiol. 32:1188-1192.
11. Curtis, J. L., G. B. Huffnagle, G. H. Chen, M. L. Warnock, M. Gyetko, R. McDonald, P. Scott, and G, B. Towes. 1994. Experimental murine pulmonary cryptococcosis. Lab. Invest. 71:113-126.
12. Fan, M., B. P. Currie, R. R. Gutell, M. A. Ragan, and A. Casadevall. 1994. The 16S-like, 5.8S, and 23S-like rRNAs of the two varieties of Cryptococcus neoformans: sequence, secondary structure, phylogenetic analysis, and restriction fragment polymorphisms. J. Med. Vet. Mycol. 32:163-180.
13. Fan, M., L. C. Chen, M. A. Ragan, R. R. Gutell, J. R. Warner, B. P. Currie, and A. Casadevall. 1995. The 5S rRNA and the rDNA intergenic spacer of the two varieties of Cryptococcus neoformans: sequence, structure, and phylogenetic implications. J. Med. Vet. Mycol. 33:215-221.
14. Feldmesser, M., and A. Casadevall. 1997. Effect of serum IgG1 to Cryptococcus neoformans glucuronoxylomannan on murine pulmonary infection. J. Immunol. 158:790-799.
15. Franzot, S. P., J. S. Hamdan, B. P. Currie, and A. Casadevall. 1997. Molecular epidemiology of Cryptococcus neoformans in Brazil and the United States: evidence for both local genetic differences and a global clonal population structure. J. Clin. Microbiol. 35:2243-2251.
16. Fries, B. C., F. Chen, B. P. Currie, and A. Casadevall. 1996. Karyotype instability in Cryptococcus neoformans infection. J. Clin. Microbiol. 34:1531-1534.
17. Goldman, D. L., S. Franzot, and A. Casadevall. 1997. Phenotypic switching in Cryptococcus neoformans, abstr. F44. In Abstracts of the 97th General Meeting of the American Society for Microbiology, 1997. American Society for Microbiology, Washington, D.C.
18. Hoag, K. A., N. E. Street, G. B. Huffnagle, and M. F. Lipscomb. 1995. Early cytokine production in pulmonary Cryptococcus neoformans infections distinguishes susceptible and resistant mice. Am. J. Respir. Cell. Mol. Biol. 13:487-495.
19. Huffnagle, G. B., G.-H. Chen, J. L. Curtis, R. A. McDonald, R. M. Strieter, and G. B. Toews. 1995. Down-regulation of the afferent phase of T cell-mediated pulmonary inflammation and immunity by a high melanin-producing strain of Cryptococcus neoformans. J. Immunol. 155:3507-3516.
20. Huffnagle, G. B., J. L. Yates, and M. F. Lipscomb. 1991. T-cell-mediated immunity in the lung: a Cryptococcus neoformans pulmonary infection model using SCID and athymic nude mice. Infect. Immun. 59:1423-1433.
21. Ito, W., Y. Iba, and Y. Kurosawa. 1993. Effects of substitutions of closely related amino acids at the contact surface in an antigen-antibody complex on the thermodynamic parameters. J. Biol. Chem. 268:16639-16047.
22. Kashino, S. S., L. M. Singer-Vermes, V. L. Calich, and E. Burger. 1990. Alterations in the pathogenecity of one Paracoccidioides brasiliensis isolate do not correlate with its in vitro growth. Mycopathologia 111:173-180.
23. Kozel, T. R. 1983. Dissociation of a hydrophobic surface from phagocytosis of encapsulated and non-encapsulated Cryptococcus neoformans. Infect. Immun. 39:1214-1219.
24. Kozel, T. R., and E. Gotschlich. 1982. The capsule of Cryptococcus neoformans passively inhibits phagocytosis of the yeast by macrophages. J. Immunol. 129:1675-1680.
25. Kozel, T. R., B. Highison, and C. J. Stratton. 1984. Localization on encapsulated Cryptococcus neoformans of serum components opsonic for phagocytosis by macrophages and neutrophils. Infect. Immun. 43:574-579.
26. Kozel, T. R., G. S. T. Pfrommer, and D. Redelman. 1987. Activated neutrophils exhibit enhanced phagocytosis of Cryptococcus neoformans opsonized with normal human serum. Clin. Exp. Immunol. 70:238-246.
27. Kwon-Chung, K. J., and J. C. Rhodes. 1986. Encapsulation and melanin formation as indicators of virulence in Cryptococcus neoformans. Infect. Immun. 51:218-223.
28. Lin, D.-B., K.-E. Su, and J.-C. Yu. 1995. Studies on cryopreservation of Toxoplasma gondii and its antigenicity in mice. Am. J. Trop. Med. Hyg. 53:392-396.
29. Lovchik, J. A., C. R. Lyons, and M. F. Lipscomb. 1995. A role for gamma interferon-induced nitric oxide in pulmonary clearance of Cryptococcus neoformans. Am. J. Respir. Cell. Mol. Biol. 13:116-124.
30. Mitchell, T. G., and J. R. Perfect. 1995. Cryptococcosis in the era of AIDS-100 years after the discovery of Cryptococcus neoformans. Clin. Microbiol. Rev. 8:515-548.
31. Mukherjee, J., M. Scharff, and A. Casadevall. 1992. Protective murine monoclonal antibodies to Cryptococcus neoformans. Infect. Immun. 60:4534-4541.
32. Mukherjee, S., S. C. Lee, and A. Casadevall. 1995. Antibodies to Cryptococcus neoformans glucuronoxylomannan enhance antifungal activity of murine macrophages. Infect. Immun. 63:573-579.
33. National Committee for Clinical Laboratory Standards. 1992. Reference method for broth dilution antifungal susceptibility testing for yeasts: proposed standard M27-P. National Committee for Clinical Laboratory Standards, Villanova, Pa.
34. Nolan, T. J., and R. Herman. 1985. Effects of long-term in vitro cultivation on Leishmania donovani promastigotes. J. Protozool. 32:70-75.
35. Nosanchuk, J. D., and A. Casadevall. 1997. Cellular charge of Cryptococcus neoformans: contributions from the capsular polysaccahride, melanin, and monoclonal antibody binding. Infect. Immun. 65:1836-1841.
36. Perfect, J. R. 1996. Fungal virulence genes as targets for antifungal chemotherapy. Antimicrob. Agents Chemother. 40:1577-1583.
37. Perfect, J. R., B. B. Magee, and P. T. Magee. 1989. Separation of chromosomes of Cryptococcus neoformans by pulsed-field gel electrophoresis. Infect. Immun. 57:2624-2627.
38. Perfect, J. R., M. M. Hobbs, D. L. Granger, and D. T. Durack. 1988. Cerebrospinal fluid macrophage response to experimental cryptococcal meningitis: relationship between in vivo and in vitro measurements of cytotoxicity. Infect. Immun. 56:849-854.
39. Perfect, J. R., N. Ketabchi, G. M. Cox, C. W. Ingram, and C. Beiser. 1993. Karyoryping of C. neoformans as an epidemiological tool. J. Clin. Microbiol. 31:3305-3309.
40. Polacheck, I., and G. A. Lebens. 1989. Electrophoretic karyotype of the pathogenic yeast Cryptococcus neoformans. J. Gen. Microbiol. 134:1037-1041.
41. Rosas, A. L., and A. Casadevall. 1997. Melanization affects susceptibility of Cryptococcus neoformans to heat and cold. FEMS Microbiol. Lett. 153:265-272.
42. Skelton, M. A., R. Cherniak, L. Poppe, and H. van Halbeek. 1991. Structure of the de-O-acetylated glucuronoxylomannan from Cryptococcus neoformans serotype D, as determined by 2D NMR spectroscopy. Magn. Reson. Chem. 29:786-793.
43. Spitzer, E. D., and S. G. Spitzer. 1992. Use of a dispersed repetitive DNA element to distinguish clinical isolates of Cryptococcus neoformans. J. Clin. Microbiol. 30:1094-1097.
44. Spitzer, E. D., S. G. Spitzer, L. F. Freundlich, and A. Casadevall. 1993. Persistence of initial infection in recurrent Cryptococcus neoformans meningitis. Lancet 341:595-596.
45. Sullivan, D., K. Haynes, G. Moran, D. Shanley, and D. Coleman. 1996. Persistence, replacement, and microevolution of Cryptococcus neoformans strains in recurrent meningitis in AIDS patients. J. Clin. Microbiol. 34:1739-1744.
46. Varma, A., and K. J. Kwon-Chung. 1989. Restriction fragment polymorphism in mitochondrial DNA of Cryptococcus neoformans. J. Gen. Microbiol. 135:3353-3362.
47. Wang, Y., P. Aisen, and A. Casadevall. 1996. Melanin, melanin "ghosts," and melanin composition in Cryptococcus neoformans. Infect. Immun. 64:2420-2424.
48. Wickes, B. L., D. E. Moore, and K. J. Kwon-Chung. 1994. Comparison of the electrophoretic karyotypes and chromosomal location of ten genes in the two varieties of Cryptococcus neoformans. Microbiology 140:543-555.
49. Wilson, D. E., J. E. Bennett, and J. W. Bailey. 1968. Serologic grouping of Cryptococcus neoformans. Proc. Soc. Exp. Biol. Med. 127:820-823.
50. Wong, M. M., S. L. Karr, and C. K. Chow. 1977. Changes in the virulence of Naegleria fowleri maintained in vitro. J. Parasitol. 5:872-877.